Clinical Trials Logo

Clinical Trial Summary

To prospectively evaluate the effectiveness and safety of SBRT in the treatment of residual malignant pulmonary nodules after lung cancer, and is committed to providing new treatment options for patients with multiple primary malignant pulmonary nodules who cannot tolerate multiple operations.

Clinical Trial Description


Study Design

NCT number NCT05113017
Study type Observational [Patient Registry]
Source Second Xiangya Hospital of Central South University
Contact Chunhong Hu, professor
Phone +86 13508486908
Email [email protected]
Status Recruiting
Start date September 15, 2021
Completion date September 14, 2024